Citylabs: crane removal marks start of final phase
The 100,000 sq
ft Citylabs development is
now reaching its final phase of construction, marked by the
dismantling of the imposing tower crane today.
Work on the new build element is
due to completed early next year, and the building is expected to
open for business mid 2014 following the restoration of the former
Royal Eye Hospital.
Biomedical companies choosing
Citylabs will benefits from its location, at the heart of Europe's
largest clinical academic campus. Companies based at Citylabs
will be able to access expertise from within our hospitals and the
wider Manchester Corridor. This will give them a better
understanding of patients' and clinicians' needs, and an
opportunity to develop new medical technologies in a clinical
setting to ensure that they are fit for purpose.
Central Manchester University
Hospitals NHS Foundation Trust is a leading provider of tertiary
and specialist healthcare services, and treats more than one
million patients each year. Our research is focused on better
understanding a diverse range of conditions, including rare
diseases, and we partner closely with The University of
Manchester. We manage over 800 clinical studies at any one
time and, in 2012, we were the second highest recruiting
Trust in England, with over 20,000 patients recruited into
studies. We're committed to ensuring that patients get high
quality of care now, but also recognise that it's important for us
to work with others to conduct and apply research, to build better
ways of working into our services for the future.